Comera Life Sciences Holdings, Inc.

The momentum for this stock is not very good. Comera Life Sciences Holdings, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Comera Life Sciences Holdings, Inc..
Log in to see more information.

News

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

Globe Newswire Dorothy Clarke\n\n Dorothy Clarke\n\n WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new...\n more…

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

Globe Newswire Final stage of technical evaluation near completion in Comera's research collaboration with Regeneron, a leading U.S. biotechnology company Expanded and strengthened Comera's global patent...\n more…

Comera Life Sciences Presents SQore  Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
Comera Life Sciences Presents SQore Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

Globe Newswire WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...\n more…

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Short Interest Update
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) Short Interest Update

Ticker Report Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA Get Free Report) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totalling...\n more…

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

Globe Newswire WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...\n more…

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities

Globe Newswire Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences ...\n more…